Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

Cell Host and Microbe - United States
doi 10.1016/j.chom.2017.03.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Use of Therapeutic Drug Monitoring in Complex Antituberculous and Antiretroviral Drug Dosing in HIV/Tuberculosis-Coinfected Patients

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2014English

Drug-Resistant Bacterial Infections in HIV Patients

2018English

Biomarkers and Bacterial Pneumonia Risk in Patients With Treated HIV Infection: A Case-Control Study

PLoS ONE
Multidisciplinary
2013English

Antiretroviral Drug Resistance Mutations Among Treated and Treatment-Naive Patients in Pakistan: Diversity of the HIV Type 1polGene in Pakistan

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2011English

Clinical Relevance of Drug Interactions in HIV-Infected Patients Receiving Antiretroviral Therapy

2011English

Review of HIV Antiretroviral Drug Resistance

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2008English

Characteristics and Outcomes of Antiretroviral-Treated HIV-HBV Co-Infected Patients in Canada?

BMC Infectious Diseases
Infectious Diseases
2019English

Drug Resistance Pattern in Pulmonary Tuberculosis Patients and Risk Factors Associated With Multi-Drug Resistant Tuberculosis

Journal of Tuberculosis Research
2017English

Tuberculosis Risk Factors and Mycobacterium Tuberculosis Transmission Among Hiv‐infected Patients in Vietnam

Respirology
PulmonaryRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy